Skip to main content
NIH funding notice PAR-22-247

Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)

Closed on May 25, 2025.

Posted
October 13, 2022
Close date
May 25, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,225,343 in first-year total cost, median $1,112,672.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BTC-Y (55)]1
  2. Special Emphasis Panel[ZRG1 CDB-W (55)]1

Most frequent institutions

  1. UNIVERSITY OF COLORADO DENVER1
  2. UNIVERSITY OF WISCONSIN-MADISON1
Competing awards under PAR-22-247 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Human Immune System Humanized Modeling of Down Syndrome Immune Responses to Pluripotent Stem Cells1R24AI197259-01BROWN, MATTHEW EUNIVERSITY OF WISCONSIN-MADISON, WI$1,488,578ZRG1
2023Trisomy 21 Model Atlas1R24OD035579-01ESPINOSA, JOAQUIN M.GALBRAITH, MATTHEW DSULLIVAN, KELLY D.UNIVERSITY OF COLORADO DENVER, CO$736,765ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-247: Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) | ScienceDex | ConductScience